BIOWOUND SOLUTIONS, INC. – Trademark Portfolio
Entity Type: 03
BIOWOUND SOLUTIONS, INC. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 7 trademarks are registered and 6 are pending. Notable registered marks include CELADIA, KERAGEL, KERAGELT, KERASORB, and THERAMEND. The owner is based in LAS VEGAS, NV.
5475 S DECATUR BLVD, SUITE 100
LAS VEGAS, NV 89118
Showing of trademarks Trademarks
Trademark Classifications
BIOWOUND SOLUTIONS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does BIOWOUND SOLUTIONS, INC. have?
BIOWOUND SOLUTIONS, INC. has 16 U.S. trademarks filed with the USPTO. Of these, 7 registered, 6 pending, 3 abandoned.
What trademark classes does BIOWOUND SOLUTIONS, INC. file in?
BIOWOUND SOLUTIONS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BIOWOUND SOLUTIONS, INC.'s most well-known trademarks?
BIOWOUND SOLUTIONS, INC.'s registered trademark portfolio includes well-known marks such as CELADIA, KERAGEL, KERAGELT, KERASORB, and THERAMEND. These are among 7 currently registered trademarks in the portfolio.
What is BIOWOUND SOLUTIONS, INC.'s trademark registration success rate?
BIOWOUND SOLUTIONS, INC. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 6 applications are pending review.